Navigation Links
NewYork-Presbyterian/Columbia physician-scientists present at ACC's 57th Annual Scientific Session
Date:3/28/2008

NEW YORK (March 27, 2008) -- Physician-scientists from NewYork-Presbyterian Hospital/Columbia University Medical Center will present their latest research findings at the American College of Cardiology's 57th Annual Scientific Session in Chicago, March 29 to April 1. Among the most significant presentations are the following:

Drug-Eluting Stents Versus Bare-Metal Stents for Transplant Allograft Vasculopathy

Dr. Jeffrey Moses Director of the Center for Interventional Vascular Therapy and director of the Cardiac Catheterization Lab at NewYork-Presbyterian Hospital/Columbia University Medical Center and professor of medicine at Columbia University College of Physicians and Surgeons

Heart transplant patients are more vulnerable to accelerated arteriosclerosis in their transplanted heart than the general population. In one of the largest studies of its kind, NewYork-Presbyterian/Columbia researchers found that drug-eluting stents were able to better keep arteries open and prevent narrowing than bare-metal stents. However, mortality rates for interventions were equal.


The Impact of Mandatory Angiographic Follow-up on the One-Year Clinical and Angiographic Results From Endeavor IV: A Randomized Comparison of the Endeavor Drug (ABT-578) Eluting Stent System vs. Taxus in De Novo Native Coronary Lesions

Dr. Martin B. Leon Associate director of the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center and professor of medicine at Columbia University College of Physicians and Surgeons. He is founder and chairman emeritus of the Cardiovascular Research Foundation in New York City.

This presentation will look at follow-up using angiograms and clinical outcomes on patients in the Endeavor IV study, which compares the Endeavor drug-eluting stent with the Taxus drug-eluting stent. The results indicate that clinical follow-up may be m
'/>"/>

Contact: Bryan Dotson
brd9005@nyp.org
212-305-5587
New York- Presbyterian Hospital/Columbia University Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. CVS Caremark Presents at NCOA-ASA Conference on Companys Commitment to Recruiting and Retaining Mature Workers
2. Gen-Probe to Webcast Presentation at Leerink Swann Molecular Diagnostics Conference
3. Clarient to Present at the B. Riley & Co. 9th Annual Las Vegas Investor Conference
4. Accurays CFO to Present at B. Riley & Company Ninth Annual Investor Conference
5. Rigel to Present at 8th Annual Fortis Bank Biotechnology Conference
6. Bionovo to Present at the Cambria Capital Investor Meeting
7. UC Irvine researchers present latest findings at emergency medicine forum
8. BD to Present at the Leerink Swann Molecular Diagnostics Roundtable Conference
9. RNR Public Relations Presents Perfect April Fools Day Feature Opportunity
10. Health Fitness to Present at B. Riley & Co. 9th Annual Las Vegas Investor Conference
11. Gourmetceuticals to Present Data from Four Studies at Experimental Biology 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Calif. (PRWEB) September 17, 2014 ... monthly interruptions, giving girls of all ages an ... wellness company founded by women, for women, announces ... Uninterrupted® (http://GirlU.com) to relieve the symptoms ... bloating and irritability. , As a lifelong ...
(Date:9/17/2014)... 17, 2014 In a new video ... William Groff, an expert on the condition known as PPP, ... penile papules , or PPP, is a condition that affects ... men may be affected as well. The condition is characterized ... , “While PPP is not a sexually transmitted disease and ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 A raucous ... Disease come together to form author Nancy Chovancek’s laughter-filled ... book is a collection of short stories that prove ... on fun. With a positive message of empowerment and ... Chovancek is a proven author with two books under ...
(Date:9/17/2014)... GA (PRWEB) September 17, 2014 ... District (DHCHD) has implemented its CollaborNet™ Health ... exchange of patients’ health information between Coon Memorial ... Texas, and physicians in the community. , ... application to enable electronic referrals by physicians to ...
(Date:9/17/2014)... Seattle, Wa (PRWEB) September 17, 2014 ... published by the Telegraph in August 2014, scientists made ... cure for diabetes, but still failed. The article indicates ... , Despite this existing fact, there are many forward-thinking ... for diabetes treatment in a natural way. Dr. Kenneth ...
Breaking Medicine News(10 mins):Health News:Girl Uninterrupted® Debuts New Look for All-Natural, PMS-Relief Supplement, Launching Today 2Health News:Girl Uninterrupted® Debuts New Look for All-Natural, PMS-Relief Supplement, Launching Today 3Health News:Girl Uninterrupted® Debuts New Look for All-Natural, PMS-Relief Supplement, Launching Today 4Health News:New Video Depicts Best Treatment for PPP 2Health News:New Video Depicts Best Treatment for PPP 3Health News:Dallam-Hartley Counties Hospital District Deploys Holon's Health Information Exchange (HIE) Solution to Facilitate Improved Patient Care 2Health News:Dallam-Hartley Counties Hospital District Deploys Holon's Health Information Exchange (HIE) Solution to Facilitate Improved Patient Care 3Health News:Discover a Safe and Effective Treatment for Diabetes with The Diabetes Protocol – Vinamy 2
... 5 seek any assistance, MORAGA, Calif., Oct. 9 ... common disorders, it is regularly under diagnosed by,medical professionals., ... -- muscle tension,headache, nausea, fatigue, or trembling -- before ... during times of stress such as a,divorce, job change ...
... Results of a multicenter study led by Johns Hopkins ... babies with hydrocortisone, a steroid believed to fight inflammation ... treatment offers little or no benefit and that low ... levels, on the other hand, appeared to increase the ...
... New Report Shows Only 17% of Employers Offer Vision Benefits, ... have taken center stage in the upcoming election, worries about,the ... minds of most,Americans. For the 120 million Americans with vision ... value on maintaining healthy vision,the lack of vision coverage is ...
... Generations agrees to sell patents to Life Spine, ... firm Life Spine, Inc. announced today that it has ... LLC. Terms of,the transaction were not disclosed., According ... property expansion is critical. "The core of the spine ...
... Oct. 8 The Hain Celestial,Group, Inc. (Nasdaq: ... food and personal,care products company, today announced that ... to make a presentation regarding the,Company on Wednesday, ... Natural Boston Conference., (Logo: http://www.newscom.com/cgi-bin/prnh/20050324/NYTH131 ...
... Predictive medicine company,PreMD Inc. (TSX: PMD; PREMF.pk) ... has completed its previously announced debenture financing ... Midsummer,Investment, Ltd. The gross proceeds of the ... general corporate purposes., "We are very ...
Cached Medicine News:Health News:40 Million Americans Endure Anxiety Everyday 2Health News:Steroid treatment offers no benefit in preemies, Hopkins Children's study suggests 2Health News:Steroid treatment offers no benefit in preemies, Hopkins Children's study suggests 3Health News:Americans Place High Value on Eyesight, Yet Many Still Lack Vision Coverage 2Health News:Americans Place High Value on Eyesight, Yet Many Still Lack Vision Coverage 3Health News:Hain Celestial to Present at Canaccord Adams Healthy Living Naturally Boston Conference on October 15, 2008 2Health News:PreMD Inc. Completes Secured Debenture Financing 2
(Date:9/16/2014)... , Sept. 16, 2014 This report analyzes the ... by the following Product Segments: SPECT Systems (Includes SPECT and ... The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... estimates and forecasts are provided for the period 2013 through ...
(Date:9/16/2014)... -- Chairman and CEO Bernard J. Tyson announced ... the role of interim chief information officer (CIO) for ... "Kaiser Permanente is a recognized leader ... high-quality care and service we provide to our 9.5 ... extensive experience in information technology. I am confident that ...
(Date:9/16/2014)... 16, 2014  Aratana Therapeutics, Inc. (NASDAQ: ... on licensing, developing and commercializing innovative biopharmaceutical products ... commencing an underwritten registered public offering of shares ... are being offered by Aratana Therapeutics. ... joint book-running managers for the offering.  ...
Breaking Medicine Technology:Global Nuclear Medicine Imaging Equipment Industry 2Global Nuclear Medicine Imaging Equipment Industry 3Global Nuclear Medicine Imaging Equipment Industry 4Global Nuclear Medicine Imaging Equipment Industry 5Global Nuclear Medicine Imaging Equipment Industry 6Global Nuclear Medicine Imaging Equipment Industry 7Global Nuclear Medicine Imaging Equipment Industry 8Global Nuclear Medicine Imaging Equipment Industry 9Global Nuclear Medicine Imaging Equipment Industry 10Global Nuclear Medicine Imaging Equipment Industry 11Global Nuclear Medicine Imaging Equipment Industry 12Global Nuclear Medicine Imaging Equipment Industry 13Global Nuclear Medicine Imaging Equipment Industry 14Global Nuclear Medicine Imaging Equipment Industry 15Global Nuclear Medicine Imaging Equipment Industry 16Global Nuclear Medicine Imaging Equipment Industry 17Global Nuclear Medicine Imaging Equipment Industry 18Global Nuclear Medicine Imaging Equipment Industry 19Global Nuclear Medicine Imaging Equipment Industry 20Global Nuclear Medicine Imaging Equipment Industry 21Global Nuclear Medicine Imaging Equipment Industry 22Global Nuclear Medicine Imaging Equipment Industry 23Global Nuclear Medicine Imaging Equipment Industry 24Global Nuclear Medicine Imaging Equipment Industry 25Global Nuclear Medicine Imaging Equipment Industry 26Kaiser Foundation Health Plan, Inc. and Kaiser Foundation Hospitals Name Interim Chief Information Officer 2Aratana Therapeutics, Inc. Announces Proposed Public Offering 2
... LLC, a global leader in,non invasive high intensity ... of the Sonablate(R) International HIFU Registry,(SIHR), along with ... Takai,Hospital Supply Co., Ltd., (THS). The SIHR is ... about prostate cancer treatment using HIFU.,It was established ...
... candidates to ... obesity patients, SAN DIEGO, July 9 Orexigen(R) Therapeutics,Inc. ... randomizing patients,in ZB-202, a second Phase IIb clinical trial for ... trial is designed,to build on highly encouraging safety and efficacy ...
Cached Medicine Technology:Sonablate(R) International HIFU Registry is the First Worldwide HIFU Clinical Registry for Prostate Cancer Treatments 2Sonablate(R) International HIFU Registry is the First Worldwide HIFU Clinical Registry for Prostate Cancer Treatments 3Orexigen(R) Initiates Second Phase IIb Empatic(TM) Trial on Schedule 2Orexigen(R) Initiates Second Phase IIb Empatic(TM) Trial on Schedule 3Orexigen(R) Initiates Second Phase IIb Empatic(TM) Trial on Schedule 4
Cholesterol FS. For determination of cholesterol in serum or plasma. Available with Calibrator: Trucal U and Controls: Trulab N, Trulab P Trulab L....
Intended for the quantitative determination of total cholesterol in serum. Single vial, dry powder reagent. Reaction: Endpoint. Wavelength: 500 nm. Linearity: 700 mg/dL (12.9 mmol/L)....
This true 8-bit integrated and cooled imaging system is a completely self contained unit built with a long list of standard features including all-electronic-variable transilluminator and EPI lightin...
... range of Platelet aggregometers allows to ... particular needs. Single, dual and four ... recorder outputs or digital computer outputs. ... aggregometers, which measure platelet aggregation in ...
Medicine Products: